The team from Tel Aviv University developed a vaccine to combat the bacterium that causes the black plague, using the same ...

Numerous lawmakers and doctors have expressed concern about the safety of the vaccine and whether the federal government and vaccine makers fully disclosed the risks.

In light of recent revelations surrounding a new intranasal COVID-19 vaccine candidate, there is growing concern that the American public is once again being led into potentially dangerous territory ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

In a historic breakthrough for global medicine, Israeli researchers have made a ground-breaking development of the world’s ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago. Indeed, if you axed Moderna off your watchlist after the ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...